Published in Trends Pharmacol Sci on April 01, 1992
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Extracellular proteolysis in the adult murine brain. J Clin Invest (1993) 1.96
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging (1997) 1.60
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett (1994) 1.32
Annual review prize lecture cytokines - killers in the brain? J Physiol (1999) 1.31
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol (2008) 1.31
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol Neurobiol (1999) 0.96
A role for brown adipose tissue in diet-induced thermogenesis. Nature (1979) 6.20
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med (1995) 3.77
Cytokines and acute neurodegeneration. Nat Rev Neurosci (2001) 3.70
ABDOMINAL INCISIONS TREATED BY THE "OPEN METHOD". Ann Surg (1927) 3.34
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med (1997) 2.95
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol (1998) 2.73
Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci (1994) 2.71
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett (1993) 2.35
Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol (1995) 2.35
Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci (1995) 2.28
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatr Pulmonol (2001) 2.20
Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci (2001) 2.20
"Life, Jim, but not as we know it"? Transmissible dementias and the prion protein. Br J Psychiatry (1991) 2.16
Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun (2009) 2.13
Systemic infection, inflammation and acute ischemic stroke. Neuroscience (2008) 2.03
Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour. Clin Sci (Lond) (1983) 1.93
Muscling in on salbutamol. Lancet (1992) 1.80
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull (1992) 1.80
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1996) 1.72
Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans (2007) 1.67
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 1.63
Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A (1999) 1.56
Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J Clin Invest (1982) 1.56
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature (1981) 1.50
How now mad cow? BMJ (1992) 1.49
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J Exp Med (1999) 1.47
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med (1986) 1.42
Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: a retrospective archival survey with implications for future research. Neurodegeneration (1995) 1.40
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett (1994) 1.32
Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease. Am J Pathol (1990) 1.30
Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol (1995) 1.28
Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep (1984) 1.26
Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) (1992) 1.26
Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun (1997) 1.25
Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med (1991) 1.24
Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res (1995) 1.23
Amyloid beta-protein, APOE genotype and head injury. Ann N Y Acad Sci (1996) 1.21
Dementia in a punch-drunk wife. Lancet (1990) 1.21
The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1999) 1.20
Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol (1990) 1.19
Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci (1998) 1.17
Influence of noradrenaline on blood flow to brown adipose tissue in rats exhibiting diet-induced thermogenesis. Pflugers Arch (1981) 1.17
Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol (1995) 1.17
Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab (1998) 1.16
An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport (1996) 1.15
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Regulation of energy balance. Annu Rev Nutr (1981) 1.14
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochir Suppl (1996) 1.13
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Neurobiol Aging (1999) 1.13
Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol Appl Neurobiol (1991) 1.13
A role for insulin in the diet-induced thermogenesis of cafeteria-fed rats. Metabolism (1981) 1.12
Location of neuronal tangles in somatostatin neurones in Alzheimer's disease. Nature (1985) 1.12
Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol (2009) 1.12
Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue. Endocrinology (1989) 1.11
Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia (1999) 1.11
Increased proton conductance pathway in brown adipose tissue mitochondria of rats exhibiting diet-induced thermogenesis. Nature (1980) 1.11
The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport (1996) 1.10
Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol (1999) 1.09
Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol (1996) 1.09
Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br J Pharmacol (2009) 1.08
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. Am J Physiol (1992) 1.06
Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J Neurol Neurosurg Psychiatry (1991) 1.05
Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience (1982) 1.03
Smoking and neurogenerative diseases. Lancet (1993) 1.02
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw (1998) 1.01
Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia. Biosci Rep (1981) 1.01
Effect of chronic food restriction on energy balance, thermogenic capacity, and brown-adipose-tissue activity in the rat. Biosci Rep (1982) 1.00
Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport (1993) 1.00
Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease. Prog Brain Res (1993) 0.99
Gliosis in schizophrenia: a survey. Biol Psychiatry (1986) 0.99
Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci (1995) 0.99
Beta-adrenoreceptors in rat brown adipose tissue: proportions of beta 1- and beta 2-subtypes. Am J Physiol (1985) 0.98
Diet-induced thermogenesis. Pharmacol Ther (1982) 0.98
Effects of manipulating dietary protein and energy intake on energy balance and thermogenesis in the pig. J Nutr (1980) 0.98
Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci (1998) 0.96
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol Neurobiol (1999) 0.96
Effects of diet and acute noradrenaline treatment on brown adipose tissue development and mitochondrial purine-nucleotide binding. Q J Exp Physiol (1982) 0.96
Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am J Physiol (1997) 0.96
Regional blood flow and skeletal muscle energy status in endotoxemic rats. Am J Physiol (1987) 0.96
Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem Soc Trans (2007) 0.95
Mechanisms of thermogenesis induced by low protein diets. Metabolism (1983) 0.94
Effects of feeding a palatable "cafeteria' diet on energy balance in young and adult lean (+/?) Zucker rats. Br J Nutr (1982) 0.94
Role of insulin in thermogenic responses to refeeding in 3-day-fasted rats. Am J Physiol (1983) 0.94
Cerebrocortical necrosis in ruminants. Occurrence of thiaminase in the gut of normal and affected animals and its effect on thiamine status. J Comp Pathol (1974) 0.94
Effects of denervating brown adipose tissue on the responses to cold, hyperphagia and noradrenaline treatment in the rat. J Physiol (1984) 0.94
Combined effects of cafeteria and tube-feeding on energy balance in the rat. Proc Nutr Soc (1979) 0.94
Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J Neuroendocrinol (2001) 0.94
Regulation of energy balance in two models of reversible obesity in the rat. J Comp Physiol Psychol (1979) 0.94
Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J Neurosci Res (1997) 0.94
Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol. Br J Pharmacol (1987) 0.94
Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia (2001) 0.93